Clinical Trials Directory

Trials / Completed

CompletedNCT03763799

Early Stop(Ruling) of the Antibiotic Treatment During Pneumopathies d' Inhalation

Impact of a Strategy Based on the Unyvero® Testing System on Appropriate Antimicrobial Treatment in Patients With Suspected Aspiration Pneumonia Requiring Mechanical Ventilation : a Randomized Controlled Unblinded Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
266 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The two most common consequences resulting from aspiration are chemical pneumonitis and bacterial aspiration pneumonia. Both entities present with comparable clinical signs and symptoms. In the absence of a reliable clinical or biological marker to differentiate between these two conditions, most patients with suspected aspiration are treated empirically with antibiotics. De-escalation of initial antibiotic treatment is encouraged based on the results of microbiological results, usually performed before starting antimicrobial treatment. However, in most hospitals, 48-72h are required to obtain the results of microbiological cultures, and to de-escalate empirical large spectrum antibiotic treatment. The use of the Unyvero®, a multiplex PCR-based testing system, for detection of respiratory bacterial pathogens would allow decreasing the percentage of patients with aspiration syndrome who will receive unappropriated antibiotic treatment at Day 3.

Conditions

Interventions

TypeNameDescription
PROCEDUREPCR-based microbiological diagnosis strategyA multiplex PCR-based testing, will be used in addition to standard microbiological culture of the tracheal aspirate to diagnose bacterial pneumonia after inhalation
PROCEDUREStandard microbiological diagnosis strategyStandard strategy will be based on with standard microbiological culture of the tracheal aspirate to diagnose bacterial pneumonia after inhalation

Timeline

Start date
2019-09-20
Primary completion
2024-02-22
Completion
2024-02-22
First posted
2018-12-04
Last updated
2025-12-23

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03763799. Inclusion in this directory is not an endorsement.